Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study
Winnie Chua(University of Birmingham), Larissa Fabritz(University of Birmingham), G Neculau(University Hospitals Birmingham NHS Foundation Trust), František Neháj(Sandwell & West Birmingham Hospitals NHS Trust), K Russell(Sandwell & West Birmingham Hospitals NHS Trust), Paulus Kirchhof(University of Birmingham), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Samantha Tull(University of Birmingham), A. Turner(Sandwell & West Birmingham Hospitals NHS Trust), Peter Kastner(Roche Pharma AG (Germany)), Muhammad Jawad‐Ul‐Qamar(University of Birmingham), Victor Roth Cardoso(University of Birmingham), Davor Pavlović(University of Birmingham), Jonathan P. Law(University Hospitals Birmingham NHS Foundation Trust), Georgios V. Gkoutos(University of Cambridge), André Ziegler(Roche (Switzerland)), Yanish Purmah(University of Birmingham), Paul Brady(University Hospitals Birmingham NHS Foundation Trust)
Cited by 18
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k